Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Assets (2018 - 2025)

Cue Biopharma's Return on Assets history spans 8 years, with the latest figure at 1.03% for Q3 2025.

  • For Q3 2025, Return on Assets fell 3.0% year-over-year to 1.03%; the TTM value through Sep 2025 reached 1.03%, down 3.0%, while the annual FY2024 figure was 0.85%, 20.0% down from the prior year.
  • Return on Assets for Q3 2025 was 1.03% at Cue Biopharma, up from 1.22% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.47% in Q1 2021 and bottomed at 1.47% in Q1 2025.
  • The 5-year median for Return on Assets is 0.66% (2023), against an average of 0.77%.
  • The largest annual shift saw Return on Assets grew 11bps in 2021 before it crashed -62bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.54% in 2021, then decreased by -17bps to 0.63% in 2022, then fell by -20bps to 0.76% in 2023, then crashed by -37bps to 1.04% in 2024, then rose by 1bps to 1.03% in 2025.
  • Per Business Quant, the three most recent readings for CUE's Return on Assets are 1.03% (Q3 2025), 1.22% (Q2 2025), and 1.47% (Q1 2025).